Nisa Investment Advisors’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-9,797
| Closed | -$964K | – | 2987 |
|
|
2025
Q2 | $964K | Sell |
9,797
-5,363
| -35% | -$507K | ﹤0.01% | 819 |
|
|
2025
Q1 | $1.4M | Buy |
15,160
+10
| +0.1% | +$922 | 0.01% | 736 |
|
|
2024
Q4 | $1.38M | Buy |
15,150
+180
| +1% | +$16.5K | 0.01% | 791 |
|
|
2024
Q3 | $1.44M | Sell |
14,970
-300
| -2% | -$29.3K | 0.01% | 757 |
|
|
2024
Q2 | $1.4M | Hold |
15,270
| – | – | 0.01% | 794 |
|
|
2024
Q1 | $1.41M | Hold |
15,270
| – | – | 0.01% | 771 |
|
|
2023
Q4 | $1.45M | Hold |
15,270
| – | – | 0.01% | 745 |
|
|
2023
Q3 | $1.43M | Hold |
15,270
| – | – | 0.01% | 765 |
|
|
2023
Q2 | $1.4M | Buy |
15,270
+300
| +2% | +$24.6K | 0.01% | 788 |
|
|
2023
Q1 | $1.1M | Buy |
14,970
+3
| +0% | +$260 | 0.01% | 835 |
|
|
2022
Q4 | $1.25M | Buy |
14,967
+3
| +0% | +$270 | 0.01% | 850 |
|
|
2022
Q3 | $1.45M | Sell |
14,964
-56
| -0.4% | -$6.68K | 0.01% | 716 |
|
|
2022
Q2 | $1.58M | Hold |
15,020
| – | – | 0.01% | 696 |
|
|
2022
Q1 | $2.59M | Buy |
+15,020
| New | +$2.24M | 0.02% | 599 |
|
|
2021
Q4 | – | Sell |
-15,230
| Closed | -$2.27K | – | 2181 |
|
|
2021
Q3 | $2.27K | Sell |
15,230
-1,744
| -10% | -$363K | 0.01% | 673 |
|
|
2021
Q2 | $4.16K | Hold |
16,974
| – | – | 0.03% | 503 |
|
|
2021
Q1 | $4.5K | Hold |
16,974
| – | – | 0.03% | 478 |
|
|
2020
Q4 | $4.98M | Buy |
16,974
+1,019
| +6% | +$261K | 0.03% | 448 |
|
|
2020
Q3 | $3.77M | Buy |
15,955
+715
| +5% | +$163K | 0.03% | 436 |
|
|
2020
Q2 | $3.03M | Sell |
15,240
-180
| -1% | -$33.6K | 0.03% | 474 |
|
|
2020
Q1 | $2.83M | Buy |
15,420
+300
| +2% | +$53.4K | 0.03% | 433 |
|
|
2019
Q4 | $2.52M | Hold |
15,120
| – | – | 0.02% | 565 |
|
|
2019
Q3 | $1.98M | Buy |
15,120
+70
| +0.5% | +$9.11K | 0.02% | 650 |
|
|
2019
Q2 | $1.83M | Hold |
15,050
| – | – | 0.02% | 666 |
|
|
2019
Q1 | $1.85M | Sell |
15,050
-50
| -0.3% | -$6.28K | 0.02% | 643 |
|
|
2018
Q4 | $1.77M | Sell |
15,100
-16,987
| -53% | -$2M | 0.02% | 601 |
|
|
2018
Q3 | $4.01M | Buy |
32,087
+16,987
| +112% | +$1.88M | 0.04% | 427 |
|
|
2018
Q2 | $1.29M | Hold |
15,100
| – | – | 0.01% | 743 |
|
|
2018
Q1 | $911K | Sell |
15,100
-50
| -0.3% | -$2.85K | 0.01% | 852 |
|
|
2017
Q4 | $799K | Hold |
15,150
| – | – | 0.01% | 904 |
|
|
2017
Q3 | $848K | Hold |
15,150
| – | – | 0.01% | 873 |
|
|
2017
Q2 | $952K | Sell |
15,150
-1,800
| -11% | -$105K | 0.01% | 826 |
|
|
2017
Q1 | $866K | Sell |
16,950
-550
| -3% | -$26.2K | 0.01% | 856 |
|
|
2016
Q4 | $746K | Hold |
17,500
| – | – | 0.01% | 910 |
|
|
2016
Q3 | $830K | Hold |
17,500
| – | – | 0.01% | 851 |
|
|
2016
Q2 | $883K | Hold |
17,500
| – | – | 0.01% | 810 |
|
|
2016
Q1 | $846K | Buy |
+17,500
| New | +$675K | 0.01% | 813 |
|
Other funds holding AMED
IA
MCI
HNB
Nisa Investment Advisors's AMED Position: Q3 2025 in Review
Nisa Investment Advisors sold out of Amedisys (AMED) in Q3 2025, closing a stake of 9,797 shares — an estimated $964K sold.
Nisa Investment Advisors first reported a position in AMED in Q1 2016 and held it in 37 quarters. The position peaked at $4.98M in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Nisa Investment Advisors reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Nisa Investment Advisors sold 9,797 Amedisys shares in Q3 2025, an estimated $964K.
- Nisa Investment Advisors first reported a position in Amedisys in Q1 2016 and held it in 37 quarters.
- Nisa Investment Advisors's Amedisys position peaked at $4.98M in Q4 2020.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Nisa Investment Advisors's 13F filing for Q3 2025, filed 23 Oct 2025.